Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Renin Versus Lactic Acid as Tissue Perfusion Biomarkers for Mortality Prediction in Hypotensive Critically Ill Patients

NCT05810415 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT05810415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05810415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Renin Versus Lactic Acid as Tissue Perfusion Biomarkers for Mortality Prediction in Hypotensive Critically Ill Patients
Lead sponsor
Al-Azhar University
Phase
Observational
Overall status
Unknown status
Start date
June 21, 2022
Completion date
January 25, 2024
Enrollment
84 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, critically ill, hypotensive, obstructive shock, sepsis